New drugs offer cancer patients hope
Pioneering immunotherapy drugs could soon be offering new hope to patients with hard-to-treat advanced cancers.
These are important results because they extend the potential for therapy to situations where there is minimal or no tumour present," Dr Giordano said.
The new nivolumab data showed two-year survival for heavily pre-treated melanoma with almost half of patients responding to treatment.
More than half of non-small cell lung cancer patients previously treated with three or more therapies also survived two years after receiving the drug.
Up to 71 per cent of patients with advanced kidney cancer who had previously been treated with drugs that target tumour blood vessels lived a year with the treatment.
All were "end-of-the-line" patients who had been given only weeks or months to live.
Via
Krishan Maggon
Your new post is loading...
Cancer patients could find out if chemotherapy is working just eight hours after their first treatment...
Learn more / En savoir plus / Mehr erfahren:
http://www.scoop.it/t/21st-century-innovative-technologies-and-developments/?tag=Cancer